News

A type of nanoparticle can activate a powerful immune response, showing promise for use as both the vaccine delivery system and as an adjuvant.

The field of RNA therapeutics is booming. But not all drugs are created equal. CSHL scientists Justin Kinney and Adrian Krainer recently teamed up to investigate why some RNA-splicing-based therapies work better than others.

A man who claimed to receive 217 vaccinations against SARS-CoV-2 has a healthy, functioning immune system, an analysis of his blood reveals.

Researchers from Japan demonstrate that gene editing can enhance the effectiveness of rejuvenated cytotoxic T lymphocytes for targeted immunotherapy.

Researchers have found a novel genetic arrangement that could help a common bacterium in the human gut protect itself from a widely used antibiotic, and have discovered previously unseen genetic arrangements that confer antibiotic resistance.

Oregon Health & Science University researchers have confirmed that the timing of COVID-19 vaccination is associated with slight, temporary changes in menstrual cycle length.

Scientists from Mass Eye and Ear and the Broad Institute of MIT and Harvard found 18 novel species of a type of bacteria called enterococci, which are gut microbes found in most land animals.

A new drug can prevent dangerous allergic reactions to small quantities of allergy-triggering foods, making life saver for children with allergies.

A University at Buffalo-led research team is developing a new recombinant flu vaccine that has the potential to compete with existing vaccines.

A UC Davis Health study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumor burden and extended the survival of mice with liver cancer.